Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference33 articles.
1. Chen C, Beckman RA. Hypothesis testing in a confirmatory phase III trial with a possible subset effect. Stat Biopharm Res. 2009;1(4):431–40.
2. U.S. Food and Drug Administration. Enrichment Strategies for Clinical Trials to Support Determination of Effectiveness of Human Drugs and Biological Products Guidance for Industry. 2019. Silver Spring.
3. Li W, Zhao J, Li XY, Chen C, Beckman AR. Multi-stage enrichment and basket trial designs with population selection. Stat Med. 2019;38:5470–85.
4. Zhang JJ, Blumenthal GM, He K, Tang S, Cortazar P, Sridhara R. Overestimation of the effect size in group sequential trials. Clin Cancer Res. 2012;18(18):4872–6.
5. Wang SJ, O’Neil R, Hung HMJ. Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset. Pharm Stat. 2007;6:227–44.